C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/861 (2006.01) C12N 5/10 (2006.01) C12N 15/64 (2006.01) C12P 19/34 (2006.01)
Patent
CA 2192442
The present invention provides multiply deficient adenoviral vectors and complementing cell lines. Also provided are recombinants of the multiply deficient adenoviral vectors and a therapeutic method, particularly relating to gene therapy, vaccination, and the like, involving the use of such recombinants.
La présente invention concerne des vecteurs adénoviraux à déficiences multiples et des lignées cellulaires complémentaires. L'invention concerne également de tels vecteurs adénoviraux, à déficiences multiples, obtenus par recombinaison, et un procédé de traitement notamment de thérapie génique, de vaccination, ou similaire, impliquant l'utilisation de tels produits de recombinaison.
Brough Douglas E.
Bruder Joseph T.
Kovesdi Imre
Lizonova Alena
Mcvey Duncan L.
Genvec Inc.
Ridout & Maybee Llp
LandOfFree
Complementary adenoviral vector systems and cell lines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Complementary adenoviral vector systems and cell lines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Complementary adenoviral vector systems and cell lines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1996435